2023-2028 Global and Regional Metastatic Colorectal Cancer Treatment Industry Status and Prospects Professional Market Research Report Standard Version

The global Metastatic Colorectal Cancer Treatment market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).

By Market Verdors:
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals

By Types:
Surgery
Chemotherapy

By Applications:
Hospitals
Clinics
Cancer Research Centers

Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market's competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.

Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Metastatic Colorectal Cancer Treatment Market Size Analysis from 2023 to 2028
1.5.1 Global Metastatic Colorectal Cancer Treatment Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Metastatic Colorectal Cancer Treatment Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Metastatic Colorectal Cancer Treatment Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Metastatic Colorectal Cancer Treatment Industry Impact
Chapter 2 Global Metastatic Colorectal Cancer Treatment Competition by Types, Applications, and Top Regions and Countries
2.1 Global Metastatic Colorectal Cancer Treatment (Volume and Value) by Type
2.1.1 Global Metastatic Colorectal Cancer Treatment Consumption and Market Share by Type (2017-2022)
2.1.2 Global Metastatic Colorectal Cancer Treatment Revenue and Market Share by Type (2017-2022)
2.2 Global Metastatic Colorectal Cancer Treatment (Volume and Value) by Application
2.2.1 Global Metastatic Colorectal Cancer Treatment Consumption and Market Share by Application (2017-2022)
2.2.2 Global Metastatic Colorectal Cancer Treatment Revenue and Market Share by Application (2017-2022)
2.3 Global Metastatic Colorectal Cancer Treatment (Volume and Value) by Regions
2.3.1 Global Metastatic Colorectal Cancer Treatment Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Metastatic Colorectal Cancer Treatment Revenue and Market Share by Regions (2017-2022)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Metastatic Colorectal Cancer Treatment Sales, Consumption, Export, Import by Regions (2017-2022)
4.1 Global Metastatic Colorectal Cancer Treatment Consumption by Regions (2017-2022)
4.2 North America Metastatic Colorectal Cancer Treatment Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Metastatic Colorectal Cancer Treatment Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Metastatic Colorectal Cancer Treatment Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Metastatic Colorectal Cancer Treatment Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Metastatic Colorectal Cancer Treatment Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Metastatic Colorectal Cancer Treatment Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Metastatic Colorectal Cancer Treatment Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Metastatic Colorectal Cancer Treatment Sales, Consumption, Export, Import (2017-2022)
4.10 South America Metastatic Colorectal Cancer Treatment Sales, Consumption, Export, Import (2017-2022)
Chapter 5 North America Metastatic Colorectal Cancer Treatment Market Analysis
5.1 North America Metastatic Colorectal Cancer Treatment Consumption and Value Analysis
5.1.1 North America Metastatic Colorectal Cancer Treatment Market Under COVID-19
5.2 North America Metastatic Colorectal Cancer Treatment Consumption Volume by Types
5.3 North America Metastatic Colorectal Cancer Treatment Consumption Structure by Application
5.4 North America Metastatic Colorectal Cancer Treatment Consumption by Top Countries
5.4.1 United States Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
5.4.2 Canada Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
5.4.3 Mexico Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
Chapter 6 East Asia Metastatic Colorectal Cancer Treatment Market Analysis
6.1 East Asia Metastatic Colorectal Cancer Treatment Consumption and Value Analysis
6.1.1 East Asia Metastatic Colorectal Cancer Treatment Market Under COVID-19
6.2 East Asia Metastatic Colorectal Cancer Treatment Consumption Volume by Types
6.3 East Asia Metastatic Colorectal Cancer Treatment Consumption Structure by Application
6.4 East Asia Metastatic Colorectal Cancer Treatment Consumption by Top Countries
6.4.1 China Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
6.4.2 Japan Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
6.4.3 South Korea Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
Chapter 7 Europe Metastatic Colorectal Cancer Treatment Market Analysis
7.1 Europe Metastatic Colorectal Cancer Treatment Consumption and Value Analysis
7.1.1 Europe Metastatic Colorectal Cancer Treatment Market Under COVID-19
7.2 Europe Metastatic Colorectal Cancer Treatment Consumption Volume by Types
7.3 Europe Metastatic Colorectal Cancer Treatment Consumption Structure by Application
7.4 Europe Metastatic Colorectal Cancer Treatment Consumption by Top Countries
7.4.1 Germany Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
7.4.2 UK Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
7.4.3 France Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
7.4.4 Italy Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
7.4.5 Russia Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
7.4.6 Spain Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
7.4.7 Netherlands Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
7.4.8 Switzerland Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
7.4.9 Poland Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
Chapter 8 South Asia Metastatic Colorectal Cancer Treatment Market Analysis
8.1 South Asia Metastatic Colorectal Cancer Treatment Consumption and Value Analysis
8.1.1 South Asia Metastatic Colorectal Cancer Treatment Market Under COVID-19
8.2 South Asia Metastatic Colorectal Cancer Treatment Consumption Volume by Types
8.3 South Asia Metastatic Colorectal Cancer Treatment Consumption Structure by Application
8.4 South Asia Metastatic Colorectal Cancer Treatment Consumption by Top Countries
8.4.1 India Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
8.4.2 Pakistan Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
Chapter 9 Southeast Asia Metastatic Colorectal Cancer Treatment Market Analysis
9.1 Southeast Asia Metastatic Colorectal Cancer Treatment Consumption and Value Analysis
9.1.1 Southeast Asia Metastatic Colorectal Cancer Treatment Market Under COVID-19
9.2 Southeast Asia Metastatic Colorectal Cancer Treatment Consumption Volume by Types
9.3 Southeast Asia Metastatic Colorectal Cancer Treatment Consumption Structure by Application
9.4 Southeast Asia Metastatic Colorectal Cancer Treatment Consumption by Top Countries
9.4.1 Indonesia Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
9.4.2 Thailand Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
9.4.3 Singapore Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
9.4.4 Malaysia Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
9.4.5 Philippines Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
9.4.6 Vietnam Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
9.4.7 Myanmar Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
Chapter 10 Middle East Metastatic Colorectal Cancer Treatment Market Analysis
10.1 Middle East Metastatic Colorectal Cancer Treatment Consumption and Value Analysis
10.1.1 Middle East Metastatic Colorectal Cancer Treatment Market Under COVID-19
10.2 Middle East Metastatic Colorectal Cancer Treatment Consumption Volume by Types
10.3 Middle East Metastatic Colorectal Cancer Treatment Consumption Structure by Application
10.4 Middle East Metastatic Colorectal Cancer Treatment Consumption by Top Countries
10.4.1 Turkey Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
10.4.3 Iran Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
10.4.5 Israel Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
10.4.6 Iraq Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
10.4.7 Qatar Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
10.4.8 Kuwait Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
10.4.9 Oman Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
Chapter 11 Africa Metastatic Colorectal Cancer Treatment Market Analysis
11.1 Africa Metastatic Colorectal Cancer Treatment Consumption and Value Analysis
11.1.1 Africa Metastatic Colorectal Cancer Treatment Market Under COVID-19
11.2 Africa Metastatic Colorectal Cancer Treatment Consumption Volume by Types
11.3 Africa Metastatic Colorectal Cancer Treatment Consumption Structure by Application
11.4 Africa Metastatic Colorectal Cancer Treatment Consumption by Top Countries
11.4.1 Nigeria Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
11.4.2 South Africa Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
11.4.3 Egypt Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
11.4.4 Algeria Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
11.4.5 Morocco Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
Chapter 12 Oceania Metastatic Colorectal Cancer Treatment Market Analysis
12.1 Oceania Metastatic Colorectal Cancer Treatment Consumption and Value Analysis
12.2 Oceania Metastatic Colorectal Cancer Treatment Consumption Volume by Types
12.3 Oceania Metastatic Colorectal Cancer Treatment Consumption Structure by Application
12.4 Oceania Metastatic Colorectal Cancer Treatment Consumption by Top Countries
12.4.1 Australia Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
12.4.2 New Zealand Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
Chapter 13 South America Metastatic Colorectal Cancer Treatment Market Analysis
13.1 South America Metastatic Colorectal Cancer Treatment Consumption and Value Analysis
13.1.1 South America Metastatic Colorectal Cancer Treatment Market Under COVID-19
13.2 South America Metastatic Colorectal Cancer Treatment Consumption Volume by Types
13.3 South America Metastatic Colorectal Cancer Treatment Consumption Structure by Application
13.4 South America Metastatic Colorectal Cancer Treatment Consumption Volume by Major Countries
13.4.1 Brazil Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
13.4.2 Argentina Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
13.4.3 Columbia Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
13.4.4 Chile Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
13.4.5 Venezuela Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
13.4.6 Peru Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
13.4.8 Ecuador Metastatic Colorectal Cancer Treatment Consumption Volume from 2017 to 2022
Chapter 14 Company Profiles and Key Figures in Metastatic Colorectal Cancer Treatment Business
14.1 Sanofi
14.1.1 Sanofi Company Profile
14.1.2 Sanofi Metastatic Colorectal Cancer Treatment Product Specification
14.1.3 Sanofi Metastatic Colorectal Cancer Treatment Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Roche
14.2.1 Roche Company Profile
14.2.2 Roche Metastatic Colorectal Cancer Treatment Product Specification
14.2.3 Roche Metastatic Colorectal Cancer Treatment Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Eli Lilly
14.3.1 Eli Lilly Company Profile
14.3.2 Eli Lilly Metastatic Colorectal Cancer Treatment Product Specification
14.3.3 Eli Lilly Metastatic Colorectal Cancer Treatment Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Pfizer
14.4.1 Pfizer Company Profile
14.4.2 Pfizer Metastatic Colorectal Cancer Treatment Product Specification
14.4.3 Pfizer Metastatic Colorectal Cancer Treatment Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Novartis
14.5.1 Novartis Company Profile
14.5.2 Novartis Metastatic Colorectal Cancer Treatment Product Specification
14.5.3 Novartis Metastatic Colorectal Cancer Treatment Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Amgen
14.6.1 Amgen Company Profile
14.6.2 Amgen Metastatic Colorectal Cancer Treatment Product Specification
14.6.3 Amgen Metastatic Colorectal Cancer Treatment Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Taiho Oncology
14.7.1 Taiho Oncology Company Profile
14.7.2 Taiho Oncology Metastatic Colorectal Cancer Treatment Product Specification
14.7.3 Taiho Oncology Metastatic Colorectal Cancer Treatment Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Genentech
14.8.1 Genentech Company Profile
14.8.2 Genentech Metastatic Colorectal Cancer Treatment Product Specification
14.8.3 Genentech Metastatic Colorectal Cancer Treatment Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 EMD Serono
14.9.1 EMD Serono Company Profile
14.9.2 EMD Serono Metastatic Colorectal Cancer Treatment Product Specification
14.9.3 EMD Serono Metastatic Colorectal Cancer Treatment Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 Suzhou Zelgen Biopharmaceuticals
14.10.1 Suzhou Zelgen Biopharmaceuticals Company Profile
14.10.2 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Product Specification
14.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Treatment Production Capacity, Revenue, Price and Gross Margin (2017-2022)
Chapter 15 Global Metastatic Colorectal Cancer Treatment Market Forecast (2023-2028)
15.1 Global Metastatic Colorectal Cancer Treatment Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Metastatic Colorectal Cancer Treatment Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Metastatic Colorectal Cancer Treatment Value and Growth Rate Forecast (2023-2028)
15.2 Global Metastatic Colorectal Cancer Treatment Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Metastatic Colorectal Cancer Treatment Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Metastatic Colorectal Cancer Treatment Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Metastatic Colorectal Cancer Treatment Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Metastatic Colorectal Cancer Treatment Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Metastatic Colorectal Cancer Treatment Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Metastatic Colorectal Cancer Treatment Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Metastatic Colorectal Cancer Treatment Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Metastatic Colorectal Cancer Treatment Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Metastatic Colorectal Cancer Treatment Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Metastatic Colorectal Cancer Treatment Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Metastatic Colorectal Cancer Treatment Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Metastatic Colorectal Cancer Treatment Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Metastatic Colorectal Cancer Treatment Consumption Forecast by Type (2023-2028)
15.3.2 Global Metastatic Colorectal Cancer Treatment Revenue Forecast by Type (2023-2028)
15.3.3 Global Metastatic Colorectal Cancer Treatment Price Forecast by Type (2023-2028)
15.4 Global Metastatic Colorectal Cancer Treatment Consumption Volume Forecast by Application (2023-2028)
15.5 Metastatic Colorectal Cancer Treatment Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 533 Airport Boulevard, Suite 400, Burlingame, CA 94010, United States

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports, 403, 4th Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).


Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2024 Worldwide Market Reports. All Rights Reserved